Scotiabank announced on 24 November 2025 that it has received all necessary regulatory approvals for the transfer of its banking operations in Colombia, Costa Rica, and Panama to Davivienda, the Colombian financial institution. The completion of the approvals process across three jurisdictions clears the final regulatory hurdle for a transaction that will see those operations consolidated under a new Davivienda Group holding entity, with Scotiabank retaining a 20% equity stake in the expanded organisation.
The deal represents a significant reshaping of Scotiabank's Latin American strategy. Canada's third-largest bank by market capitalisation has historically maintained a wide network across the region, but its leadership has articulated a strategic intent to concentrate capital and management attention on markets where it holds leading positions with deeper commercial relationships. The transfer of direct operational control in Colombia, Costa Rica, and Panama to Davivienda reflects that portfolio rationalisation, while the retained 20% stake preserves financial exposure to the long-term performance of those businesses.
OPERATIONS TO MOVE UNDER DAVIVIENDA HOLDING ENTITY
The regulatory approval process required clearance from the relevant supervisory authorities in each of Colombia, Costa Rica, and Panama, as well as from Canadian regulators overseeing the seller's side of the transaction. Securing simultaneous approvals across multiple jurisdictions with different regulatory timelines, review processes, and documentation requirements is logistically complex, and the completion of that multi-country approval process confirms that each authority reviewed and accepted the transaction without imposing material conditions. The Scotiabank announcement did not specify a formal legal closing date beyond confirming that all approvals had been received as at 24 November 2025.
The regulatory approval process required clearance from the relevant supervisory authorities in each of Colombia, Costa Rica, and Panama, as well as from Canadian regulators overseeing the seller's side of the transaction. Securing simultaneous approvals across multiple jurisdictions with different regulatory timelines and review processes is logistically complex, and the completion of that multi-country approval process signals that the transaction is now in its closing phase. The Scotiabank announcement did not specify a formal legal closing date beyond confirming that all approvals had been received.
SCOTIABANK REFOCUSES ITS REGIONAL PRESENCE
Scotiabank's approach to its Latin American portfolio has been closely watched by investors seeking clarity on the bank's capital-allocation priorities following a period in which its international operations generated mixed returns relative to its Canadian peers. The decision to exit direct operational control in three markets while retaining a meaningful minority stake in Davivienda offers a middle path: reducing the management complexity and capital intensity of a dispersed multi-country network while maintaining upside exposure through a stake in a larger, consolidated regional entity.
The 20% stake in the expanded Davivienda gives Scotiabank a significant minority position in a financial institution that will rank among the larger banks in Central and South America by asset size following the additions. Investors have tracked the progress of this Latin American portfolio restructuring as an indicator of management's execution capability against stated strategic priorities, and the receipt of all regulatory approvals in Colombia, Costa Rica, and Panama marks a concrete and substantive milestone in that process. Scotiabank confirmed the development in a statement published on 24 November 2025.